PUBLISHER: QYResearch | PRODUCT CODE: 1609534
PUBLISHER: QYResearch | PRODUCT CODE: 1609534
The global Pentanediamine market was valued at US$ 12.82 million in 2023 and is anticipated to reach US$ 84.13 million by 2030, witnessing a CAGR of 32.85% during the forecast period 2024-2030.
The major global manufacturers of Pentanediamine include Cathay Biotech Inc and Ning Xia Eppen Biotech, in 2023, the world's top two vendors accounted for approximately 100 % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Pentanediamine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pentanediamine.
The Pentanediamine market size, estimations, and forecasts are provided in terms of output/shipments (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pentanediamine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pentanediamine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Segment by Application
Production by Region
Consumption by Region